Ligand validation:3NJO

PYV: 4-bromo-N-(pyridin-2-ylmethyl)naphthalene-1-sulfonamide

PYV is a Ligand Of Interest in 3NJO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NJO_PYV_C_300	32%	0%	0.251	0.924	6	3.2	11	17	7	0	100%	0.4
3NJO_PYV_A_300	3%	1%	0.514	0.862	5.41	2.5	11	12	1	0	100%	0.3864
5UR4_PYV_A_201	94%	7%	0.079	0.977	3.22	1.67	2	6	0	0	100%	0.9032
3OJI_PYV_B_210	79%	5%	0.114	0.96	3.69	1.71	5	7	0	0	100%	1
3NJ1_PYV_A_300	78%	4%	0.12	0.963	3.67	1.98	3	6	0	0	100%	0.5
5ZCU_PYV_C_301	70%	5%	0.14	0.957	2.03	3.32	5	8	3	0	100%	1
3NEF_PYV_A_201	66%	4%	0.167	0.973	3.85	1.81	4	4	2	0	100%	0.94
3NS2_PYV_C_191	56%	4%	0.149	0.922	3.67	1.89	5	4	1	0	100%	0.66

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.